Ecovyst Inc.
At today's price, Ecovyst Inc. (ECVT) is priced for +12.7% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
Ecovyst is in a strong upcycle: first-quarter 2026 adjusted EBITDA surged 87% to $39.8 million, revenue jumped about 50% to $215 million and beat by 13%, virgin sulfuric acid volumes rose more than 30% with the Waggaman assets, and management raised 2026 guidance to sales of $890 million to $970 million and EBITDA of $180 million to $195 million. The valuation models disagree sharply: growth and margin-ramp frames mark from $19 to $63, but the conservative book-value and earnings-power frames l
Is ECVT overvalued? See what's priced in →
189 institutional managers reported holding ECVT in 13F filings for the quarter ended 2026-03-31. 47 opened new positions that quarter. Held by Vanguard Group, BlackRock, Dimensional Fund Advisors, among others. On the short side, 3.6M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (2.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ECVT has cut its share count 18.7% over the past five years, spending $304.31M on repurchases. It pays no dividend. Cash returned over the past three years: $94.19M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ECVT over the trailing three years: 2023: 2 buys totaling $78k; 2024: 4 buys totaling $213k. 12 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ECVT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-05-06 | -7.2% | +10.2% |
| 2023-08-09 | -17.3% | -2.7% |
| 2023-11-04 | +4.5% | -1.5% |
| 2024-03-01 | -1.4% | +7.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ECVT's latest 8-K filings: 2026-06-30 (items 1.01, 2.03, 8.01, 9.01); 2026-05-21 (items 5.07); 2026-05-05 (items 2.02, 9.01); 2026-05-04 (items 1.01, 9.01); 2026-02-26 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.